UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2403-2413

1997

Volltextzugriff (PDF)

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

Journal of clinical oncology, 1997-11, Vol.15 (11), p.3394-3398

1997

Volltextzugriff (PDF)

Dose ranging pharmacokinetic trial of high‐dose alicaforsen (intercellular adhesion molecule‐1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease

Alimentary pharmacology & therapeutics, 2002-10, Vol.16 (10), p.1761-1770

2002

Volltextzugriff (PDF)

Potential antiproliferative activity of polyphenol metabolites against human breast cancer cells and their urine excretion pattern in healthy subjects following acute intake of a polyphenol-rich juice of grumixama (Eugenia brasiliensis Lam.)

Food & function, 2017-06, Vol.8 (6), p.2266-2274

2017

Volltextzugriff (PDF)

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer

British journal of cancer, 2001-11, Vol.85 (11), p.1753-1758

2001

Volltextzugriff (PDF)

Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-raf-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2227-2236

1999

Volltextzugriff (PDF)

Potential Role of Tamoxifen in Prevention of Breast Cancer

JNCI : Journal of the National Cancer Institute, 1991-10, Vol.83 (20), p.1450-1459

1991

Volltextzugriff (PDF)

Forced degradation study and characterization of main impurities of ibuprofen soft gelatin capsules by LC-MS-QTOF

Pharmazie, 2021-04, Vol.76 (4), p.138-144

2021

Volltextzugriff (PDF)

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Cancer chemotherapy and pharmacology, 1999, Vol.44 (5), p.372-380

1999

Volltextzugriff (PDF)

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2842-2850

1995

Volltextzugriff (PDF)

A metal-free blue chromophore derived from plant pigments

Science advances, 2020-04, Vol.6 (14), p.eaaz0421

2020

Volltextzugriff (PDF)

c-raf-1 Depletion and Tumor Responses in Patients Treated with the c-raf-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A)

Clinical cancer research, 1999-12, Vol.5 (12), p.3977-3982

1999

Volltextzugriff (PDF)

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

The New England journal of medicine, 1989-08, Vol.321 (7), p.419-424

1989

Volltextzugriff (PDF)

Tamoxifen and fenretinide in women with metastatic breast cancer

Breast cancer research and treatment, 1999-10, Vol.57 (3), p.277-283

1999

Volltextzugriff (PDF)

Antisense Approaches for the Treatment of Cancer

Cancer investigation, 2000, Vol.18 (7), p.635-650

2000

Volltextzugriff (PDF)

Phase I Trial of ISIS 5132, an Antisense Oligonucleotide Inhibitor of c-raf-1, Administered by 24-hour Weekly Infusion to Patients with Advanced Cancer

Clinical cancer research, 2001-05, Vol.7 (5), p.1214-1220

2001

Volltextzugriff (PDF)

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial

Journal of clinical oncology, 2023-12, Vol.41 (36), p.5482-5492

2023

Volltextzugriff (PDF)

Leuprolide With and Without Flutamide in Advanced Prostate Cancer

Cancer, 1990-09, Vol.66 (5), p.1039-1044

1990

Volltextzugriff (PDF)

Metastatic bladder cancer: Advances in treatment

European journal of cancer (1990), 1997, Vol.33, p.S23-S26

1997

Volltextzugriff (PDF)

Prognostic factors observed in current clinical trials

Cancer, 1993-03, Vol.71 (S6), p.2163-2168

Dorr, F. Andrew

1993

Volltextzugriff (PDF)

Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 1996-02, Vol.14 (1), p.45-61

1996

Volltextzugriff (PDF)

Perspectives of digestive pest control with proteinase inhibitors that mainly affect the trypsin-like activity of Anticarsia gemmatalis Hübner (Lepidoptera: Noctuidae)

Brazilian journal of medical and biological research, 2005-11, Vol.38 (11), p.1633-1641

2005

Volltextzugriff (PDF)

A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients

Annals of oncology, 1994-10, Vol.5 (8), p.709-716

1994

Volltextzugriff (PDF)

National cancer institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo

Seminars in oncology, 1991-10, Vol.18 (5), p.9-12

1991

Volltextzugriff (PDF)

The role of chemotherapy in the management of primary breast cancer

CA: a cancer journal for clinicians, 1991-07, Vol.41 (4), p.231-241

1991

Volltextzugriff (PDF)

1 – 25 von 1.092

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(901)
Mit Volltextzugriff
(883)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

Dose ranging pharmacokinetic trial of high‐dose alicaforsen (intercellular adhesion molecule‐1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease

Potential antiproliferative activity of polyphenol metabolites against human breast cancer cells and their urine excretion pattern in healthy subjects following acute intake of a polyphenol-rich juice of grumixama (Eugenia brasiliensis Lam.)

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer

Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-raf-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)

Potential Role of Tamoxifen in Prevention of Breast Cancer

Forced degradation study and characterization of main impurities of ibuprofen soft gelatin capsules by LC-MS-QTOF

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation

A metal-free blue chromophore derived from plant pigments

c-raf-1 Depletion and Tumor Responses in Patients Treated with the c-raf-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A)

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

Tamoxifen and fenretinide in women with metastatic breast cancer

Antisense Approaches for the Treatment of Cancer

Phase I Trial of ISIS 5132, an Antisense Oligonucleotide Inhibitor of c-raf-1, Administered by 24-hour Weekly Infusion to Patients with Advanced Cancer

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial

Leuprolide With and Without Flutamide in Advanced Prostate Cancer

Metastatic bladder cancer: Advances in treatment

Prognostic factors observed in current clinical trials

Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancer

Perspectives of digestive pest control with proteinase inhibitors that mainly affect the trypsin-like activity of Anticarsia gemmatalis Hübner (Lepidoptera: Noctuidae)

A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients

National cancer institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo

The role of chemotherapy in the management of primary breast cancer

Suchergebnisse filtern